Rx Medicare

Pacira Pharmaceuticals, Inc., an acute care specialty pharmaceutical company, announced that its Phase III study of its new analgesic EXPAREL(TM) (DepoBupivacaine) in patients undergoing a bunionectomy procedure met its primary endpoint. The multicenter, randomized, double-blind, parallel-group, placebo controlled study showed a statistically significant reduction in area under the curve analysis (AUC) of the NRS scores in the subjects receiving EXPAREL(TM) compared to placebo (p=0.

Read More…

Related Posts

• Third Party Reexamination Of Javelin Pharmaceuticals’ Phase III Trial Data For Ereska Yields Statistically Significant Primary Endpoint
• China Aoxing Pharmaceutical Company Announces Successful Completion Of Phase II Clinical Study Of Novel Menstrual Pain Drug
• QRxPharma Initiates Pivotal Phase 3 Study Of MoxDuo(TM)IR For Moderate To Severe Acute Pain
• Transdel Pharmaceuticals Announces Positive Phase 3 Study Results For Lead Topical Pain Drug Ketotransdel(R)
• QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study For MoxDuo(TM) IV Pain Therapy
• AcelRx Announces Positive Phase 2 Results From A Study Of ARX-01 Sufentanil NanoTabs In Treating Post-Operative Pain
• MAP Pharmaceuticals Phase 3 Trial Of Levadex? Migraine Product Candidate Meets All Four Primary Endpoints
• MAP Pharmaceuticals Phase 3 Trial Of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
• KAI Pharmaceuticals Initiates Third Phase 2a Study In Program To Develop KAI-1678 For The Treatment Of Neuropathic Pain
• KAI Pharmaceuticals Expands KAI-1678 Development Program, Initiating A Phase 2a Study For Neuropathic Pain
• Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine
• Acute Study Demonstrates Safety Of Vertos Medical’s Mild(R) Procedure; Findings Appear In Pain Physician Journal
• Significant amount of inappropriate CT and MRI referrals from primary care physicians, study finds
• Multi-Center Data In A Large Series Of Patients Show Vertebroplasty Provides Dramatic And Lasting Pain Relief For Vertebral Compression Fractures
• Alkermes Announces Positive Results For Phase 1 Study Of New Drug Candidate For Treatment Of Opioid-Induced Constipation

Tags: endpoint, expareltm, meets, paciras, pain, phase, primary, relief, study

This entry was posted on Wednesday, October 21st, 2009 at 1:10 pm and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.